Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Kujiraoka

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Atherosclerosis and Thrombosis|January 23, 2016
Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery DiseaseTsuyoshi Nozue, Hiroaki Hattori, Kazuyuki Ogawa, et al.
Lipids in Health and Disease|September 24, 2016
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery diseaseTsuyoshi Nozue, Hiroaki Hattori, Kazuyuki Ogawa, et al.
Journal of Human Genetics|March 28, 2002
Eight novel mutations and functional impairments of the LDL receptor in familial hypercholesterolemia in the north of JapanHiroaki Hattori, Tsunenori Hirayama, Yukiko Nobe, et al.
Journal of Human Genetics|July 12, 2002
Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosisJun Ishii, Makoto Nagano, Takeshi Kujiraoka, et al.
Journal of Human Genetics|May 19, 2004
Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patientsMitsuaki Ishihara, Tadao Iwasaki, Makoto Nagano, et al.
Atherosclerosis|April 17, 2016
Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factorsKazuyuki Ogawa, Takahiro Ueno, Tadao Iwasaki, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 13, 2012
Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluidNorman E Miller, Waldemar L Olszewski, Hiroaki Hattori, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2014
Removal of plasma mature and furin-cleaved proprotein convertase subtilisin/kexin 9 by low-density lipoprotein-apheresis in familial hypercholesterolemia: development and application of a new assay for PCSK9Mika Hori, Mitsuaki Ishihara, Yumiko Yuasa, et al.
Journal of Lipid Research|June 18, 2005
A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentrationMitsuaki Ishihara, Takeshi Kujiraoka, Tadao Iwasaki, et al.
Journal of Atherosclerosis and Thrombosis|March 1, 2021
A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 DeficiencyRyo Nishikawa, Masato Furuhashi, Mika Hori, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Atherosclerosis and Thrombosis|January 23, 2016
Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/kexin Type 9 and Sortilin Levels in Statin-Naive Patients with Coronary Artery DiseaseTsuyoshi Nozue, Hiroaki Hattori, Kazuyuki Ogawa, et al.
Lipids in Health and Disease|September 24, 2016
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery diseaseTsuyoshi Nozue, Hiroaki Hattori, Kazuyuki Ogawa, et al.
Journal of Human Genetics|March 28, 2002
Eight novel mutations and functional impairments of the LDL receptor in familial hypercholesterolemia in the north of JapanHiroaki Hattori, Tsunenori Hirayama, Yukiko Nobe, et al.
Journal of Human Genetics|July 12, 2002
Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosisJun Ishii, Makoto Nagano, Takeshi Kujiraoka, et al.
Journal of Human Genetics|May 19, 2004
Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patientsMitsuaki Ishihara, Tadao Iwasaki, Makoto Nagano, et al.
Atherosclerosis|April 17, 2016
Soluble sortilin is released by activated platelets and its circulating levels are associated with cardiovascular risk factorsKazuyuki Ogawa, Takahiro Ueno, Tadao Iwasaki, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 13, 2012
Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluidNorman E Miller, Waldemar L Olszewski, Hiroaki Hattori, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2014
Removal of plasma mature and furin-cleaved proprotein convertase subtilisin/kexin 9 by low-density lipoprotein-apheresis in familial hypercholesterolemia: development and application of a new assay for PCSK9Mika Hori, Mitsuaki Ishihara, Yumiko Yuasa, et al.
Journal of Lipid Research|June 18, 2005
A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentrationMitsuaki Ishihara, Takeshi Kujiraoka, Tadao Iwasaki, et al.
Journal of Atherosclerosis and Thrombosis|March 1, 2021
A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 DeficiencyRyo Nishikawa, Masato Furuhashi, Mika Hori, et al.
Pageof 2